本頁面由Tiger Trade Technology Pte. Ltd.提供服務

10x Genomics, Inc.

65.20
+0.94001.46%
成交量:14.58萬
成交額:943.63萬
市值:84.95億
市盈率:-110.81
高:65.74
開:64.10
低:63.00
收:64.26
52周最高:66.94
52周最低:11.16
股本:1.30億
流通股本:1.18億
量比:0.63
換手率:0.12%
股息:- -
股息率:- -
每股收益(TTM):-0.5884
每股收益(LYR):-0.3490
淨資產收益率:-9.40%
總資產收益率:-5.05%
市淨率:10.29
市盈率(LYR):-186.79

資料載入中...

2026/04/28

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/13

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/13

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

重要事件披露

Form 8-K - Current report
2025/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/07

重要事件披露

Form 8-K - Current report
2025/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]